Novorapid FlexPen 100 U/ML

Novorapid FlexPen 100 U/ML contains Insulin Aspart, a fast-acting insulin analog designed to help manage blood glucose levels immediately after meals. It starts working within 10–20 minutes of injection, peaks around 1–3 hours, and lasts up to 5 hours, making it an ideal choice for mealtime glucose control.

The Novorapid FlexPen offers convenience, precision, and flexibility with its prefilled, easy-to-use design — ensuring accurate dosing and reliable performance. It can be used alongside long-acting insulin for comprehensive diabetes management.

Key Benefits:

• Fast-acting insulin for post-meal glucose control

• Easy-to-use, prefilled FlexPen for precise dosing

• Starts working quickly within 10–20 minutes

• Helps prevent high blood sugar after meals

• Suitable for type 1 and type 2 diabetes management

Dosage & Administration:
Inject Novorapid FlexPen 100 U/ML subcutaneously immediately before or up to 10 minutes after a meal, as directed by a healthcare professional. Rotate injection sites to prevent skin irritation.

Precautions:
Use only under medical supervision. Monitor blood sugar regularly. Store refrigerated and avoid freezing. Do not share pens.